Grimaudo, V <br/><br/>
Fibrinolytic and anticoagulant activity after a single subcutaneous administration of a low dose of heparin or a low molecular weight heparin-dihydroergotamine combination.  [electronic resource] 

 -  Thrombosis and haemostasis  Jun 1988 
 - 388-91 p.  digital 
<br/><br/> Publication Type: Clinical Trial; Comparative Study; Controlled Clinical Trial; Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>0340-6245 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adolescent<br/>Adult<br/>Blood Coagulation--drug effects<br/>Circadian Rhythm--drug effects<br/>Dihydroergotamine--administration & dosage<br/>Drug Combinations<br/>Factor Xa<br/>Fibrinolysis--drug effects<br/>Heparin--pharmacology<br/>Heparin, Low-Molecular-Weight--administration & dosage<br/>Humans<br/>Injections, Subcutaneous<br/>Male<br/>Serine Proteinase Inhibitors